Clinical Trial Update: Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is testing ESHAOx (etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin) for refractory or relapsed Hodgkin lymphoma; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Etoposide (Toposar) (etoposide)
• Methylprednisolone (Solu-Medrol) (methylprednisolone)
• Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Hodgkin's Lymphoma | Phase 2 | Status: UNKNOWN